Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Date:2/23/2012

.24$
.20$
.17$
.97(1) Shares for the quarter and year ended December 31, 2010, exclude the weighted average effect of the shares issued as an incentive to induce conversion of the 2023 Notes in August 2010. (2) Shares for the quarter ended December 31, 2010, include the dilutive effect of stock options, restricted stock outstanding, assumed conversion of the 2012 Notes and assumed conversion of the February 2015 Notes. These shares were excluded from the GAAP net loss per diluted share calculation because they were anti-dilutive.PDL BIOPHARMA, INC. GENERAL AND ADMINISTRATIVE EXPENSE DATA(Unaudited)(In thousands) Three Months Ended December 31,Year Ended
December 31,2011201020112010Operating expenses:General and administrativeCompensation and benefits$ 1,470$
,103$   4,428$
4,065Legal expense1,7808,4947,94229,315Professional services6733252,6742,943Insurance169185724793Stock-based compensation131138387662Depreciation14145891Other5851,7972,1253,527Total general and administrative expenses4,82212,05618,33841,396Legal settlement-92,500-92,500Total operating expenses$ 4,822$ 104,556$ 18,338$ 133,896PDL BIOPHARMA, INC. CONDENSED CONSOLIDATED BALANCE SHEET DATA(Unaudited)(In thousands) December 31,20112010Cash, cash equivalents and investments$  227,946$  248,229Total assets$  269,471$  316,666Convertible notes payable$  316,615$  310,428Non-recourse notes payable$
93,370$  204,270Total stockholders' deficit$ (204,273)$ (324,182)PDL BIOPHARMA, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW DATA (Unaudited)(In thousands) Year Ended December 31,20112010Net income$ 199,389$   91,874Adjustments to reconcile net income to net cash provided by operating activities43,57421,777Changes in assets and liabilities(73,181)70,649Net cash provided by operating activities$ 169,782$ 184,300 PDL BIOPHARMA, INC. MIX OF EX-U.S. SALES AND EX-U.S.-BASED MANUFACTURING AND SALES

OF GENENTECH PRODUCTS(Unaudite
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Ondine Biopharma Announces Second Quarter 2008 Financial Results
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
7. Therapure Biopharma Inc. opens for business with first client contracts
8. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
9. China Biopharma Effects 1 for 100 Reverse Stock Split
10. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
11. FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... WuXi NextCODE, which provides comprehensive capabilities for using the genome ... genetics on their publication of the largest studies of whole-genome ... today online in Nature Genetics – ... of sequence variation, authored by a team of deCODE scientists ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
(Date:3/25/2015)... the HAGUE, Netherlands , March 25, ... LES Stimulation therapy for chronic gastro-esophageal reflux disease (GERD) ... [ Surgery . 2015; 157(3):556-567 ], establishing ... therapy. The study included 25 patients ... years and taking prescribed daily proton pump inhibitor (PPI) ...
(Date:3/25/2015)... March 25, 2015  18 piglets born recently ... research by scientists in the College of Agriculture and ... a breakthrough in the field of genetic engineering. ... of Animal & Avian Sciences (ANSC) and Ki-Eun ... successfully produced genome-edited pigs using a recently developed, ...
Breaking Biology Technology:Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2
... ... ... 2010 -- ProRepro today announced it has become an Autodesk authorized value-added reseller (VAR). ... Southern California. ProRepro’s qualified staff demonstrates in-depth technical and industry knowledge and a commitment ...
... , AMSTERDAM, The Netherlands , May 6, 2010 , ... - CFO Piers Morgan Appointed to Management Board , , , ... , , ... Annual General Meeting,(AGM) of the Company Professor Sander van Deventer has been appointed to the,Supervisory Board. , ...
... purification, faster computers, tougher shoe soles, and lighter and ... University of Technology (QUT) scientist has discovered a way ... Fuchs, from QUT,s School of Physical and Chemical Sciences, ... for dispersing metals in nanoparticle form throughout polymers or ...
Cached Biology Technology:ProRepro Becomes a Value-Added Reseller for Autodesk 2Professor Sander van Deventer Appointed to Supervisory Board of AMT 2Professor Sander van Deventer Appointed to Supervisory Board of AMT 3
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
(Date:3/11/2015)... , March 11, 2015   The ... its platform to scientifically measure and harness music ... to real-time biometrics and objective measurements of physiology, ... music at scale in large populations. It is ... technologists and clinicians perform rigorous studies and accelerate ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... to treating infectious diseases is being developed by researchers ... MRSA (Methicillin Resistant Staphylococcus Aureus) are resistant to one ... aid the treatment of infection. , A team in ... awarded £800,000 by the Wellcome Trust to commercially develop ...
... at the Stowers Institute for Medical Research, and Olivier ... the Howard Hughes Medical Institute, are the first and ... network of cyclic genes that shed light on the ... , The paper was published on Science Express, ...
... recently identified the molecular signature of these epidermal neural ... resolves conflicting scientific opinions by showing that these cells ... cells/progenitors. Their work provides a valuable resource for future ... on the research from Dr. Maya Sieber-Blum's laboratory, co-authored ...
Cached Biology News:Stem cells found in adult hair follicles may provide alternative to embryonic stem cells 2
... performance agitation and temperature control for microbiology ... wells independently and is suitable for DASGIP ... working volume. Its temperature ranges from approximately ... well is equipped with an individual electrical ...
... SYBR Green II RNA gel stain ... has bright fluorescence when bound to RNA and ... use with either formaldehyde/agarose or polyacrylamide gels using ... stains 100 minigels. A 500 µL unit size ...
Sirtuin 7 (SIRT7) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: Other Recommended Storage: Long term: -20C; Short term: +4C...
... introduced QPatch HT is taking automated patch clamping ... With its ability to generate thousands of high ... new screening paradigms in ion channel drug discovery ... same high quality afforded by conventional patch clamping ...
Biology Products: